Trials / Completed
CompletedNCT00948155
Measuring Smoking Behaviors While Using Varenicline
Assessment of Smoking Topography and Behaviors During Response to Varenicline
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will demonstrate the behavioral responses to varenicline, helping to better understand its mechanisms. Hypotheses for the study are to observe decreases in smoking topography and nicotine cigarette choice on varenicline, relative to placebo; and decreases on day 21 relative to day 7 during varenicline treatment. We also propose to examine if extended duration of treatment has clinical significance in decreasing smoking behaviors, thus increasing the efficacy of varenicline.
Detailed description
This study is designed to examine the behavioral responses a cigarette smoker may have to using varenicline. Behavioral responses may help to better understand its mechanisms which in turn could improve treatment outcomes. The primary hypothesis for the study is to observe decreases in smoking topography, an objective measure of smoking behavior or puffing, on varenicline, relative to placebo; and decreases on day 21 relative to day 7 during varenicline treatment. We will also examine puffing and nicotine cigarette choices during lab visits at baseline, and Days 7 and 21. We also propose to examine if extended duration of treatment has clinical significance in decreasing smoking behaviors, thus potentially increasing the efficacy of varenicline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline | Intervention Drug (Varenicline (Chantix) will be administered in standard dosing in pill format: 0.5 mg days 1-3; 0.5 mg bid daily days 4-7; 1.0 mg bid daily days 8-21. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-07-29
- Last updated
- 2014-12-16
- Results posted
- 2014-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00948155. Inclusion in this directory is not an endorsement.